Keep that in mind, and progress slowly. A mini basketball is a little more challenging than a tennis ball, but it's easy to palm and that helps. See if you can get high enough to get your hand over the rim--almost up to your wrist--so you can stuff the mini ball. If you can't throw it down with a little authority, a bigger basketball won't be any easier.
Start with a ping-pong ball, then a tennis ball, then a softball, then a volleyball, then a youth-sized basketball, and on up until you can dunk with a regulation size ball. If you can't palm the ball, then you will need to learn how to control the ball with two hands until the last minute extension for the dunk with one hand, or you will have to jump high enough to dunk two-handed.
The slam dunk is usually the highest percentage shot and a crowd-pleaser. Thus, the maneuver is often extracted from the basketball game and showcased in slam dunk contests such as the NBA Slam Dunk Contest held during the annual NBA All-Star Weekend. The first incarnation of the NBA Slam Dunk Contest was held during the half-time of the 1976 American Basketball Association All-Star Game.
Of course, these forces increase linearly with increasing body weight. Therefore Olympic high-jumpers are usually build more like marathon runners and less like football players. Every unnecessary pound adds to the forces during take-off, and at some point the muscles and tendons of the jumping leg are just not strong enough any more to support all the weight.
Randomization was performed in computer-generated, permuted blocks of 6 to 10, stratified according to the participating ICU. Treatment assignments and a five-digit reference number were placed in sealed, opaque envelopes, which were opened by the person responsible for the preparation of the trial-drug solutions. The solutions of norepinephrine or dopamine were prepared in vials or syringes according to the preference of the local ICU. Each vial or syringe was then labeled with its randomly allocated number. The doctors and nurses administering the drugs, as well as the local investigators and research personnel who collected data, were unaware of the treatment assignments. The trial was approved by the ethics committee at each participating center. Written informed consent was obtained from all patients or next of kin.
We conducted this multicenter trial between December 19, 2003, and October 6, 2007, in eight centers in Belgium, Austria, and Spain. All patients 18 years of age or older in whom a vasopressor agent was required for the treatment of shock were included in the study. The patient was considered to be in shock if the mean arterial pressure was less than 70 mm Hg or the systolic blood pressure was less than 100 mm Hg despite the fact that an adequate amount of fluids (at least 1000 ml of crystalloids or 500 ml of colloids) had been administered (unless there was an elevation in the central venous pressure to >12 mm Hg or in pulmonary-artery occlusion pressure to >14 mm Hg) and if there were signs of tissue hypoperfusion (e.g., altered mental state, mottled skin, urine output of <0.5 ml per kilogram of body weight for 1 hour, or a serum lactate level of >2 mmol per liter). Patients were excluded if they were younger than 18 years of age; had already received a vasopressor agent (dopamine, norepinephrine, epinephrine, or phenylephrine) for more than 4 hours during the current episode of shock; had a serious arrhythmia, such as rapid atrial fibrillation (>160 beats per minute) or ventricular tachycardia; or had been declared brain-dead.